Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 44 results:
Author Title Type [ Year] Filters: Keyword is Chemotherapy, Adjuvant [Clear All Filters]
Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome..
Clin Breast Cancer. 19(2), 113-125.e4.
(2019). The Immunohistochemical Expression MTA 1 Protein and its Prognostic Value in Pancreatic Cancer..
J Invest Surg. 31(2), 142-150.
(2018). Primary malignant melanoma of the ascending colon..
BMJ Case Rep. 2018,
(2018).
(2018). Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases..
Langenbecks Arch Surg. 402(4), 599-605.
(2017). Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers..
Cancer Genomics Proteomics. 14(3), 181-195.
(2017). Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study..
PLoS One. 11(10), e0164013.
(2016). Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes..
Breast Cancer Res Treat. 158(2), 307-21.
(2016). Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin..
Clin Colorectal Cancer. 15(2), 164-9.
(2016). Potential pleiotropic beneficial effects of adjuvant melatonergic treatment in posttraumatic stress disorder..
J Pineal Res. 61(1), 3-26.
(2016).
(2016). Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer..
J Natl Cancer Inst. 107(8),
(2015). The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping..
Breast. 23(3), 234-43.
(2014). Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG)..
Breast Cancer Res Treat. 148(3), 591-7.
(2014).
(2014). Imiquimod as neoadjuvant treatment for giant keratoacanthoma arising on a background of lupus vulgaris..
Clin Exp Dermatol. 39(1), 60-2.
(2014). A new mathematical model for the interpretation of translational research evaluating six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon..
PLoS One. 9(1), e86375.
(2014). ranibizumab in the management of advanced Coats disease Stages 3B and 4: long-term outcomes..
Retina. 34(11), 2275-81.
(2014). [Ureteroarterial fistula - pathogenesis, diagnostics, and therapeutic outcome]..
Aktuelle Urol. 45(3), 204-8.
(2014). Giant GIST of the small intestine in a young man..
J Gastrointest Surg. 17(8), 1536-7.
(2013). Primary neuroendocrine neoplasms of the larynx. A series of 4 cases reported and a review of the literature..
Head Neck. 35(6), E187-93.
(2013). Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel..
PLoS One. 7(6), e37946.
(2012). HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy..
J Transl Med. 10, 10.
(2012). Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial..
Breast Cancer Res Treat. 132(2), 609-19.
(2012). Primary ovarian small cell carcinoma of pulmonary type with enlarged paraaortic lymph node masses: a case report and review of the literature..
Eur J Gynaecol Oncol. 33(3), 312-5.
(2012).